British consumer healthcare company Haleon said on Friday it has agreed to increase its stake in its Chinese joint venture to 88% from 55% for 4.47 billion yuan ($637.35 million).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
